Coalition for Epidemic Preparedness Innovations (CEPI). Working to end epidemics & pandemics by developing new vaccines for a safer world.
#100DaysMission
📣A CEPI-funded first-ever Phase II Lassa vaccine trial has been launched by IAVI in Nigeria.
The trial at
@HJFMRI
in Abuja is designed in consultation with partners including
@NCDCgov
and the Nigeria Lassa Vaccine Taskforce.
📢 Check out CEPI's ongoing Call for Proposals: Innovations to Prepare for Future Epidemics and Pandemics.
This Call is seeking innovators to speed up development of and equitable access to safe & effective vaccines against epidemic & pandemic viral threats.
⬇️ Find out more ⬇️…
The Hantavirus family is a group of viruses normally carried by rats, mice and other rodents and is known to cause severe disease and trigger deadly outbreaks. Learn more via
@CEPIvaccines
:
Dr Donald Grant stepped up to finish the work of his mentor who died from
#Ebola
.
@CEPIvaccines
’ latest impact story looks at how he is now rebuilding the research programme on
#lassafever
in Sierra Leone:
“Lassa [fever] is predominantly seen in West Africa, so having Africans taking the lead makes it very engaging for us. It helps us to push ourselves forward in our work"
Dr Donald Grant discusses his work on the Enable study for a new CEPI Impact Story.
The Hantavirus family—behind diseases like Hantavirus Pulmonary Syndrome—has two distinct subgroups: the Old World Hantaviruses, found in Africa, Asia, & Europe, and the New World Hantaviruses, found in the Americas.
Learn more in The Viral Most Wanted ➡️